Genome Profiling Email Format

BiotechnologyPennsylvania, United States2-10 Employees

Genome Profiling is a biotechnology research company focused on the immune system, developing molecular diagnostic tests that stratify drug response using epigenomic data. Its cloud-based EpiMarker Platform analyzes genome-wide epigenetic changes in circulating white blood cells to identify biomarkers that become non-intrusive blood tests.

Its first product in development is a precision EpiMarker blood test to diagnose Endometriosis, the inaugural entry in a planned pipeline of five tests. Endometriosis is a painful, progressive pelvic disease affecting about 15% of women aged 13–40, for which diagnosis currently relies on invasive laparoscopic surgery with accuracy that varies by surgeon. The company pursues cooperative development and licensing partnerships with biopharma, molecular diagnostics, and genomic testing firms, aiming to translate immuno-EpiMarkers into commercial tests within about 18 months for licensing to partners. Based in Wayne, Pennsylvania, the company operates with a small team to pursue these diagnostic and drug-response solutions for oncology and non-oncology diseases where current approaches are limited.

Get verified Genome Profiling emails free

Company overview Employee directory